CCL11 and neoplasm: Furthermore the Oncostatin M or Eotaxin neutralizing antibody treated 4T1 tumors appeared much less vascularized as compared to control 4T1 tumors (Fig. 8B) as evaluated through immunofluorescence analysis of endoethelial cell specific marker CD31 within 4T1 tumor sections (Suppl.7).